Press Releases

12345678910
Bioceres Crop Solutions to Host Fiscal Third Quarter 2026 Financial Results Conference Call on Tuesday, May 12, 2026 at 8:30 a.m. Eastern Time
Bioceres Crop Solutions Corp. (NASDAQ: BIOX) (“Bioceres” or the “Company”), a leader in the development and commercialization of productivity solutions designed to regenerate agricultural ecosystems while making crops more resilient to climate change, will hold a conference call on Tuesday, May 12, 2026 at 8:30 a.m. Eastern Time to discuss its results for the fiscal third quarter ended March 31, 2026. A press release detailing these results will be issued prior to the call.
onsemi Reports First Quarter 2026 Results
Year-over-year operating income growth outpaces revenue growth by 2x
By onsemi · Via GlobeNewswire · May 4, 2026
James River Announces First Quarter 2026 Results
CHAPEL HILL, N.C., May 04, 2026 (GLOBE NEWSWIRE) -- Chapel Hill, N.C., May 4, 2026 - James River Group Holdings, Inc. ("James River" or the "Company") (NASDAQ: JRVR) today reported the following results for the first quarter of 2026 as compared to the same period in 2025:
Shimmick Corporation to Announce First Quarter 2026 Financial Results on May 14, 2026
IRVINE, Calif., May 04, 2026 (GLOBE NEWSWIRE) -- Shimmick Corporation (“Shimmick”) (Nasdaq: SHIM), a national leader in complex infrastructure solutions, today announced that the company will release its first quarter 2026 financial results after market close on Thursday, May 14, 2026.
By Shimmick Corporation · Via GlobeNewswire · May 4, 2026
Mesabi Trust Press Release
Quarterly Royalty Report and Royalty Payment
By Mesabi Trust · Via Business Wire · May 4, 2026
Silvaco Announces Participation at Upcoming Investor Conferences
SANTA CLARA, Calif., May 04, 2026 (GLOBE NEWSWIRE) -- Silvaco Group, Inc. (Nasdaq: SVCO) (“Company”, “Silvaco”), a provider of TCAD, EDA software, and SIP solutions that enable innovative semiconductor design and digital twin modeling through AI software and automation, today announced that Chief Executive Officer, Walden Rhines, and Chief Financial Officer, Chris Zegeralli, will be participating at upcoming investor conferences. Details for each event are as follows:
By Silvaco · Via GlobeNewswire · May 4, 2026
ThredUp Announces First Quarter 2026 Results
OAKLAND, Calif., May 04, 2026 (GLOBE NEWSWIRE) -- ThredUp Inc. (Nasdaq: TDUP, LTSE: TDUP), one of the largest online resale platforms for apparel, shoes, and accessories, announced today its financial results for the first quarter ended March 31, 2026 and updated full year 2026 financial outlook.
By ThredUp Inc. · Via GlobeNewswire · May 4, 2026
EverQuote Announces First Quarter 2026 Financial Results
CAMBRIDGE, Mass., May 04, 2026 (GLOBE NEWSWIRE) -- EverQuote, Inc. (Nasdaq: EVER), a leading provider of growth solutions for property and casualty, or P&C, insurance providers, today announced financial results for the first quarter ended March 31, 2026.
By EverQuote, Inc. · Via GlobeNewswire · May 4, 2026
Clip Money Inc. Announces Amendment of Unsecured Convertible Notes
TORONTO, May 04, 2026 (GLOBE NEWSWIRE) -- Clip Money Inc. (TSX-V: CLIP) (“Clip Money” or the “Company”), a company that operates a multi-bank self-service deposit system for businesses, is pleased to announce that, in support of strengthening its liquidity and maximizing working capital for future growth, it will (i) extend the maturity date (the “Maturity Date”) of the first tranche of the previously issued unsecured convertible notes dated May 4, 2023 (the “First Tranche Convertible Notes”) from May 4, 2026 to May 4, 2027 for all note holders who have consented to such extension, and (ii) offer an equivalent extension of the Maturity Date to all holders of the second tranche of the previously issued unsecured convertible notes dated June 14, 2023 (the “Second Tranche Convertible Notes” and, together with the First Tranche Convertible Notes, the “Convertible Notes”) from June 14, 2026 to June 14, 2027.
By Clip Money Inc · Via GlobeNewswire · May 4, 2026
NFT LTD Files Annual Report on Form 20-F for Fiscal Year 2025
Hong Kong, May 04, 2026 (GLOBE NEWSWIRE) -- NFT Ltd ("NFT" or the "Company") (NYSE American: MI), an emerging online trading platform operator of international art and collectibles, today announced that it filed its annual report on Form 20-F for the fiscal year ended December 31, 2025 with the Securities and Exchange Commission ("SEC") on May 1, 2026. The annual report can be accessed on the SEC's website at http://www.sec.gov as well as on the Company's investor relations website at https://www.nftoeo.com/investor.html.
By NFT Ltd · Via GlobeNewswire · May 4, 2026
Lexicon Pharmaceuticals Announces $100 Million Loan Facility with Hercules Capital
$55 million funded at closing to repay existing loan facility
CoinShares ETPs Now Available on Bourse Direct as France Opens Retail Access to Regulated Crypto Products
4 May 2026 | SAINT HELIER, Jersey | CoinShares PLC ("CoinShares" or "the Group") (Nasdaq: CSHR), a global leading asset manager specializing in digital assets today announced that 5 products of its range of physically-backed crypto Exchange-Traded Products (ETPs) are now available to retail investors through Bourse Direct, one of France's leading online brokerage platforms.
By CoinShares PLC · Via GlobeNewswire · May 4, 2026
ORIC® Pharmaceuticals Reports First Quarter 2026 Financial Results and Operational Updates
Announced selection of rinzimetostat RP3D in combination with darolutamide for Himalayas-1 Phase 3 global registrational trial in post-abiraterone mCRPC, expected to initiate in 1H 2026
By ORIC Pharmaceuticals · Via GlobeNewswire · May 4, 2026
Aktis Oncology Initiates Phase 1b Clinical Trial for AKY-2519, a B7-H3 Miniprotein Radioconjugate, in Metastatic Castration-Resistant Prostate Cancer (mCRPC)
BOSTON, May 04, 2026 (GLOBE NEWSWIRE) -- Aktis Oncology, Inc. (NASDAQ:AKTS) (Aktis or the Company), a clinical-stage oncology company focused on expanding the breakthrough potential of targeted radiopharmaceuticals to large populations, today announced the initiation of a Phase 1b clinical trial of AKY-25191 in patients with metastatic castration-resistant prostate cancer (mCRPC). The mCRPC-dedicated Phase 1b trial is part of Aktis’ clinical development strategy to develop AKY-2519 broadly in B7-H3 expressing tumors. Aktis plans to initiate a Phase 1b basket trial in lung, colorectal, and other high B7-H3 expressing solid tumors in the second half of 2026.
By Aktis Oncology Inc. · Via GlobeNewswire · May 4, 2026
Option Care Health to Participate in the Bank of America Health Care Conference
BANNOCKBURN, Ill., May 04, 2026 (GLOBE NEWSWIRE) -- Option Care Health, Inc. (“Option Care Health”) (Nasdaq: OPCH), the nation’s largest independent provider of home and alternate site infusion services, will participate in the Bank of America Health Care Conference, being held in Las Vegas, on Tuesday, May 12, 2026, including a fireside chat at 10:40am PT/1:40pm ET. The webcast will be available online at https://investors.optioncarehealth.com.
By Option Care Health, Inc. · Via GlobeNewswire · May 4, 2026
Neostella Opens NeoSummit 2026 This Week as Legal Leaders Face Rising Pressure to Operate Differently
Neostella will host NeoSummit 2026 May 6 and 7 at the Fort Lauderdale Marriott Harbor Beach Resort. The goal of NeoSummit is to bring together legal leaders for two days focused on the future of legal work while reflecting on a shift happening across the industry.
By Neostella · Via Business Wire · May 4, 2026
Starbucks Corporation Commences Cash Tender Offers for Eight Series of Notes
Starbucks Corporation (Nasdaq: SBUX) (“Starbucks,” “we,” “us” or the “Company”) today announced the commencement of tender offers to purchase (each offer a “Tender Offer” and collectively, the “Tender Offers”), subject to the terms and conditions of the Tender Offers described the Offer to Purchase dated May 4, 2026 (the “Offer to Purchase”), in the order of priority set forth in the table below (the “Acceptance Priority Level”) for an Aggregate Purchase Price of up to $1.1 billion, as may be increased or decreased by the Company in accordance with applicable law (the “Aggregate Cap”), in cash from each registered holder of the applicable series of Notes (each, a “Holder” and, collectively, the “Holders”), consisting of:
By Starbucks Corporation · Via Business Wire · May 4, 2026
Ocugen Announces Private Offering of $115 Million of Convertible Senior Notes
MALVERN, Pa., May 04, 2026 (GLOBE NEWSWIRE) -- Ocugen, Inc. (“Ocugen” or the “Company”) (NASDAQ: OCGN), a pioneering biotechnology leader in gene therapies for blindness diseases, today announced its intention to offer, subject to market conditions and other factors, $115 million aggregate principal amount of Convertible Senior Notes due 2034 (the “notes”) in a private offering (the “offering”) to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the “Securities Act”). Ocugen also expects to grant the initial purchaser of the notes a 13-day option to purchase up to an additional $15 million aggregate principal amount of the notes. The offering is subject to market and other conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering.
By Ocugen · Via GlobeNewswire · May 4, 2026
OSI Systems Reports Fiscal 2026 Third Quarter Financial Results
OSI Systems, Inc. (the “Company” or “OSI Systems”) (NASDAQ: OSIS) today announced its financial results for the third quarter of fiscal 2026.
By OSI Systems, Inc. · Via Business Wire · May 4, 2026
Advanced Energy Reports First Quarter 2026 Results
Advanced Energy Industries, Inc. (Nasdaq: AEIS), a global leader in highly engineered, precision power conversion, measurement, and control solutions, announced financial results for the first quarter ended March 31, 2026.
Sonos Reports Second Quarter Fiscal 2026 Results
Sonos, Inc. (Nasdaq: SONO) today reported Second Quarter Fiscal 2026 results.
By Sonos. · Via Business Wire · May 4, 2026
Travere Therapeutics Reports First Quarter 2026 Financial Results
Travere Therapeutics, Inc. (Nasdaq: TVTX) today reported its first quarter 2026 financial results and provided a corporate update.
By Travere Therapeutics, Inc. · Via Business Wire · May 4, 2026
McGrath to Participate in the Oppenheimer 21st Annual Industrial Growth Conference
McGrath RentCorp (“McGrath” or the “Company”) (Nasdaq: MGRC), a leading business-to-business rental company in North America, today announced that it will participate in the Oppenheimer 21st Annual Industrial Growth Conference that will be held virtually on Wednesday, May 6, 2026.
By McGrath RentCorp · Via Business Wire · May 4, 2026
Vertex Reports First Quarter 2026 Financial Results
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today reported consolidated financial results for the first quarter ended March 31, 2026, and reiterated its full year 2026 financial guidance.
Biodesix Announces First Quarter 2026 Results and Highlights
Delivered $25.6 million in revenue representing 42% growth in Q1 2026;
By Biodesix, Inc. · Via GlobeNewswire · May 4, 2026
Hemab Therapeutics Announces Closing of Upsized Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
CAMBRIDGE, Mass. and COPENHAGEN, Denmark, May 04, 2026 (GLOBE NEWSWIRE) -- Hemab Therapeutics Holdings, Inc. (Nasdaq: COAG), a clinical-stage biotechnology company developing therapies that reimagine the treatment of blood coagulation disorders to sustain life and human resilience, today announced the closing of its initial public offering of 19,262,500 shares of its common stock at a public offering price of $18.00 per share, including 2,512,500 additional shares of common stock issued upon the exercise in full by the underwriters of their option to purchase additional shares. All of the shares of common stock were sold by Hemab. Hemab’s common stock began trading on the Nasdaq Global Select Market on Friday, May 1, 2026 under the ticker symbol “COAG.” The gross proceeds of the offering, before deducting underwriting discounts and commissions and other offering expenses payable by Hemab, were approximately $346.7 million.
By Hemab Therapeutics, Inc. · Via GlobeNewswire · May 4, 2026
STAAR Surgical to Host First Quarter 2026 Earnings Results Call and Webcast on May 13, 2026
STAAR Surgical Company (NASDAQ: STAA), the global leader in phakic IOLs with the EVO family of Implantable Collamer® Lenses (EVO ICL™) for vision correction, today announced that it will release financial results in combination with a shareholder letter for the first quarter ended April 3, 2026, on Wednesday, May 13, 2026, after the market close. The Company will also host an earnings call and webcast at 5:30 p.m. ET to discuss its financial results and business progress.
By STAAR Surgical Company · Via Business Wire · May 4, 2026
FibroBiologics Reports Preclinical Data Showing Fibroblast Spheroids May Actively Reprogram the Burn Wound Environment to Drive Healing and Reduce Scarring
HOUSTON, May 04, 2026 (GLOBE NEWSWIRE) -- FibroBiologics, Inc. (Nasdaq: FBLG) ("FibroBiologics"), a clinical-stage biotechnology company with 270+ patents issued and pending with a focus on the development of therapeutics and potential cures for chronic diseases using fibroblasts and fibroblast-derived materials, today announced compelling preclinical results suggesting that topical treatment with human dermal fibroblast (HDF) spheroids may reprogram the burn wound environment by dampening harmful inflammation, reshaping immune cell behavior, and reducing markers of scar-forming activity, within just eight days of injury.
By FibroBiologics, Inc. · Via GlobeNewswire · May 4, 2026
Omnicell to Present at the BofA Securities 2026 Healthcare Conference
Omnicell, Inc. (Nasdaq:OMCL), a leading healthcare technology provider focused on empowering autonomous medication management, announced that it will present at the BofA Securities 2026 Healthcare Conference on Tuesday, May 12, 2026, at 8:40 a.m. PDT.
By Omnicell, Inc. · Via Business Wire · May 4, 2026
Praxis Precision Medicines to Report First Quarter 2026 Financial Results on Thursday, May 7, 2026, and Participate in Upcoming Investor Conference
BOSTON, May 04, 2026 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a fully integrated, leading central nervous system (CNS) precision neuroscience biopharmaceutical company, today announced it will report its financial results for the first quarter ended March 31, 2026, and provide a corporate update before the financial markets open on Thursday, May 7, 2026.
Senseonics Announces Closing of $92 Million Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
GERMANTOWN, Md., May 04, 2026 (GLOBE NEWSWIRE) -- Senseonics Holdings, Inc. (NASDAQ: SENS), a medical technology company focused on the design, development and commercialization of long-term, implantable continuous glucose monitoring (CGM) systems for people with diabetes, today announced the closing of its previously announced underwritten public offering of $92 million of shares of its common stock and, in lieu of common stock to certain investors, pre-funded warrants. Senseonics sold 10,400,000 shares of its common stock, which includes the full exercise of the underwriters’ option to purchase 2,400,000 additional shares of common stock, and 8,000,000 pre-funded warrants. The shares of common stock were sold at a price to the public of $5.00 per share and the pre-funded warrants were sold at a purchase price of $4.999 per share, which equals the public offering price per share of the common stock less the $0.001 exercise price per share of each pre-funded warrant. The gross proceeds to Senseonics from the offering were approximately $92.0 million, before deducting underwriting discounts and commissions and other offering expenses payable by Senseonics.
By Senseonics Holdings, Inc. · Via GlobeNewswire · May 4, 2026
DH Consulting Group of Raymond James Has Been Named as One of The Nation’s Top DC Advisor Teams
DH Consulting Group of Raymond James has been named to the prestigious National Association of Plan Advisors’ (NAPA) list of the nation’s top defined contribution (DC) Advisor Teams with assets under advisement of at least $100 million.
Visionary Holdings Inc. Announces Receipt of Nasdaq Delisting Determination Letter Related to Delinquent Listing Fees
TORONTO, May 04, 2026 (GLOBE NEWSWIRE) -- Visionary Holdings Inc. (NASDAQ: GV) (the “Company” or “Visionary”) today announced that it received a staff determination letter from The Nasdaq Stock Market LLC (“Nasdaq”) on April 29, 2026, notifying the Company that it was not in compliance with Nasdaq Listing Rule 5250(f) due to delinquent listing fees and that Nasdaq had determined to delist the Company’s securities unless the Company timely requested a hearing before the Nasdaq Hearings Panel.
By Visionary Holdings Inc. · Via GlobeNewswire · May 4, 2026
JOBSOHIO, AILERON EXPAND ELIGIBILITY FOR SMALL BUSINESS ACADEMY
Building on two years of impact across Ohio’s small business community, the program opens its doors wider for Cohort 3
By JobsOhio · Via GlobeNewswire · May 4, 2026
Tim Lamb Group Brokers the Sale of Friendship Ford of Lenoir in North Carolina to CarHeroes
Columbus, OH, May 04, 2026 (GLOBE NEWSWIRE) -- The Tim Lamb Group,  the largest auto dealership sales and acquisitions firm in North America, is pleased to announce it has represented the seller, Friendship Automotive, in the successful sale of Friendship Ford of Lenoir. The 25,258 square-foot dealership, located at 515 Wilkesboro Blvd. NE., in Lenoir, North Carolina has been renamed CarHeroes Ford, and was purchased by CarHeroes President, Matthew Nunlist.
By Tim Lamb Group · Via GlobeNewswire · May 4, 2026
HyOrc Provides Indicative Methanol Production Cost Range and Commercial Positioning Following Technology Validation
HOUSTON, May 04, 2026 (GLOBE NEWSWIRE) -- HyOrc Corporation (OTCQB: HYOR) today shared an update on the commercial positioning of its waste-to-methanol platform following the Company’s recently announced independent validation by Bureau Veritas.
By HyOrc Corporation · Via GlobeNewswire · May 4, 2026
Providence Saint John’s Health Center Reinforces its Commitment to Maternal and Newborn Care Through Newly Named Maria Shriver Labor, Delivery and Family Wellness Unit
Newly named labor, delivery and family wellness unit reflects a holistic, family-centered approach
Sterlington Advises DMMS Purchaser, Inc. in Completion of Merger with MC Bancshares, Inc.
Sterlington advised the management team and investor group behind DMMS Purchaser, Inc. ("DMMS"), led by former IBERIABANK Corp. leaders Daryl Byrd, Mark Tipton, Michael Brown, and Scott Price, on the closing of its merger with MC Bancshares, Inc., the holding company for M C Bank & Trust Company ("MCBANK"). Upon completion of the merger, DMMS will change its name to MC Bancshares, Inc. ("MCBI").
By Sterlington PLLC · Via Business Wire · May 4, 2026
New Documentary Campaign Highlights the Importance of Veteran Choice in Navigating VA Disability Claims
The National Association for Veterans Rights (NAVR) today announced the launch of a new documentary-style campaign, The Right to Choose: Veterans Helping Veterans, debuting May 4 in recognition of Military Appreciation Month.
Legent Health Appoints Brad Stoltz as Chief Operating Officer
Legent Health (“Legent”), a physician-partnered owner and operator of ambulatory surgery centers (“ASCs”) and surgical hospitals focused on orthopedic and spine care, announced Brad Stoltz as their new Chief Operating Officer.
By Legent Health · Via Business Wire · May 4, 2026
Awatif Mohammad Shoqi Advocates & Legal Consultancy Launches Comprehensive Guide to the Legal Framework of Real Estate in Dubai
DUBAI, UAE / ACCESS Newswire / May 4, 2026 / Awatif Mohammad Shoqi Advocates & Legal Consultancy today announced the publication of a detailed guide titled "The Legal Framework of Real Estate in Dubai," a structured resource that explains statutory regimes, registration requirements and dispute resolution mechanisms relevant to market participants and legal practitioners. The guide consolidates the provisions of Law No. 7 of 2006, Law No. 14 of 2008, Law No. 6 of 2019, Decree No. 23 of 2022 and the landlord-tenant regime under Law No. 26 of 2007 as amended by Law No. 33 of 2008, and places particular emphasis on Rental Disputes Settlement procedures, the registration of real estate rights and practical implications for investors and tenants.
Via ACCESS Newswire · May 4, 2026
Gabb Music Named a 2026 NAPPA Awards Winner
Safer music streaming for kids recognized by the National Parenting Product Awards for giving kids the music they love — without the content parents worry about
By Gabb Wireless Inc. · Via GlobeNewswire · May 4, 2026
Regulatory Affairs Attorney Scott Thomas Joins Dorsey in Phoenix
Scott Thomas has joined Dorsey & Whitney LLP as Of Counsel in the Firm’s Regulatory Affairs group in Phoenix, the international law firm announced today.
By Dorsey & Whitney LLP · Via Business Wire · May 4, 2026
TeraWulf Announces Participation in Upcoming Investor and Industry Conferences
EASTON, Md., May 04, 2026 (GLOBE NEWSWIRE) -- TeraWulf Inc. (Nasdaq: WULF) (“TeraWulf” or the “Company”), a leading owner and operator of vertically integrated digital infrastructure, today announced that members of senior management will participate in the following upcoming conferences and events:
By TeraWulf Inc. · Via GlobeNewswire · May 4, 2026
Four Stratix Leaders Recognized on CRN 2026 Women of the Channel List in Record Year of Honors
PEACHTREE CORNERS, GA / ACCESS Newswire / May 4, 2026 / Stratix Corporation, the industry leader in managed mobility services (MMS), announced today that CRN®, a brand of the The Channel Company, has named four teammates to the prestigious Women of the Channel list for 2026, marking the most Stratix leaders ever recognized in a single year. Two of the four honorees also earned distinction on CRN's Power 80 Solution Provider list, highlighting the growing influence and depth of Stratix's team.
Via ACCESS Newswire · May 4, 2026
Pretium Surpasses $3B in Financing to Homebuilders and Multifamily Developers
Pretium, a specialized investment firm with over $60 billion in assets under management, today announced a milestone of $3 billion in residential lending to homebuilders and multifamily developers since the launch of its residential debt platform in December 2024. In partnership with Anchor Loans, one of the Firm’s strategic real estate lending businesses, the capital provided by Pretium has supported the construction of more than 13,000 housing units to date.
By Pretium · Via Business Wire · May 4, 2026
Billor Launches Billor Driver, the Mobile Platform Powering the Truck Driver Journey
A mobile platform that unifies the entire truck driver journey — from first application to daily operations
By Billor Holding LLC · Via GlobeNewswire · May 4, 2026
CRN Recognizes 11 Employees at Climb Channel Solutions on the 2026 Women of the Channel List and Names Climb’s Chief Marketing Officer as one of the 2026 Women of the Channel Power 100
This recognition reinforces Climb’s role in advancing innovation, leadership, and collaboration in the channel
By Climb Channel Solutions · Via GlobeNewswire · May 4, 2026
Anthem, SOCA Mark Decade of Helping Ohio Small Businesses Lower Healthcare Costs
Anthem Blue Cross and Blue Shield in Ohio and the Southern Ohio Chamber Alliance (SOCA), along with four other chamber alliances, are celebrating the 10th anniversary of their landmark partnership, the SOCA Benefit Plan, an innovative health plan that has transformed access to affordable health coverage for small businesses across Ohio.
Roadzen Announces Pricing of $8 Million Registered Direct Offering of Ordinary Shares
NEW YORK, May 04, 2026 (GLOBE NEWSWIRE) -- Roadzen Inc. (Nasdaq: RDZN) (“Roadzen” or the “Company”), a global leader in AI at the convergence of insurance and mobility, today announced that it has entered into a securities purchase agreement with institutional investors for the purchase and sale of 4,705,870 ordinary shares at an offering price of $1.70 per share, in a registered direct offering (the “Offering”).
By Roadzen Inc. · Via GlobeNewswire · May 4, 2026